258 related articles for article (PubMed ID: 31156702)
21. A long non-coding RNA signature to improve prognostic prediction in clear cell renal cell carcinoma.
Zhang J; Zhang X; Piao C; Bi J; Zhang Z; Li Z; Kong C
Biomed Pharmacother; 2019 Oct; 118():109079. PubMed ID: 31351427
[TBL] [Abstract][Full Text] [Related]
22. A Gene Module-Based eQTL Analysis Prioritizing Disease Genes and Pathways in Kidney Cancer.
Yang MQ; Li D; Yang W; Zhang Y; Liu J; Tong W
Comput Struct Biotechnol J; 2017; 15():463-470. PubMed ID: 29158875
[TBL] [Abstract][Full Text] [Related]
23. Gene expression analysis in clear cell renal cell carcinoma using gene set enrichment analysis for biostatistical management.
Maruschke M; Reuter D; Koczan D; Hakenberg OW; Thiesen HJ
BJU Int; 2011 Jul; 108(2 Pt 2):E29-35. PubMed ID: 21435154
[TBL] [Abstract][Full Text] [Related]
24. Fifteen hub genes associated with progression and prognosis of clear cell renal cell carcinoma identified by coexpression analysis.
Wang Y; Chen L; Wang G; Cheng S; Qian K; Liu X; Wu CL; Xiao Y; Wang X
J Cell Physiol; 2019 Jul; 234(7):10225-10237. PubMed ID: 30417363
[TBL] [Abstract][Full Text] [Related]
25. The miR(21/10b) ratio as a prognostic marker in clear cell renal cell carcinoma.
Fritz HKM; Lindgren D; Ljungberg B; Axelson H; Dahlbäck B
Eur J Cancer; 2014 Jul; 50(10):1758-1765. PubMed ID: 24793999
[TBL] [Abstract][Full Text] [Related]
26. FOXC2 and CLIP4 : a potential biomarker for synchronous metastasis of ≤7-cm clear cell renal cell carcinomas.
Ahn J; Han KS; Heo JH; Bang D; Kang YH; Jin HA; Hong SJ; Lee JH; Ham WS
Oncotarget; 2016 Aug; 7(32):51423-51434. PubMed ID: 27283491
[TBL] [Abstract][Full Text] [Related]
27. Prognostic Value of a Long Non-coding RNA Signature in Localized Clear Cell Renal Cell Carcinoma.
Qu L; Wang ZL; Chen Q; Li YM; He HW; Hsieh JJ; Xue S; Wu ZJ; Liu B; Tang H; Xu XF; Xu F; Wang J; Bao Y; Wang AB; Wang D; Yi XM; Zhou ZK; Shi CJ; Zhong K; Sheng ZC; Zhou YL; Jiang J; Chu XY; He J; Ge JP; Zhang ZY; Zhou WQ; Chen C; Yang JH; Sun YH; Wang LH
Eur Urol; 2018 Dec; 74(6):756-763. PubMed ID: 30143382
[TBL] [Abstract][Full Text] [Related]
28. Identification of a three-miRNA signature as a novel potential prognostic biomarker in patients with clear cell renal cell carcinoma.
Luo Y; Chen L; Wang G; Xiao Y; Ju L; Wang X
J Cell Biochem; 2019 Aug; 120(8):13751-13764. PubMed ID: 30957284
[TBL] [Abstract][Full Text] [Related]
29. Transcriptome-proteome integration of archival human renal cell carcinoma biopsies enables identification of molecular mechanisms.
Koch E; Finne K; Eikrem Ø; Landolt L; Beisland C; Leh S; Delaleu N; Granly M; Vikse BE; Osman T; Scherer A; Marti HP
Am J Physiol Renal Physiol; 2019 May; 316(5):F1053-F1067. PubMed ID: 30838877
[TBL] [Abstract][Full Text] [Related]
30. Clinical utility of the S3-score for molecular prediction of outcome in non-metastatic and metastatic clear cell renal cell carcinoma.
Büttner F; Winter S; Rausch S; Hennenlotter J; Kruck S; Stenzl A; Scharpf M; Fend F; Agaimy A; Hartmann A; Bedke J; Schwab M; Schaeffeler E
BMC Med; 2018 Jul; 16(1):108. PubMed ID: 29973214
[TBL] [Abstract][Full Text] [Related]
31. Definition and verification of novel metastasis and recurrence related signatures of ccRCC: A multicohort study.
Jiang A; Pang Q; Gan X; Wang A; Wu Z; Liu B; Luo P; Qu L; Wang L
Cancer Innov; 2022 Aug; 1(2):146-167. PubMed ID: 38090653
[TBL] [Abstract][Full Text] [Related]
32. A five-long non-coding RNA signature to improve prognosis prediction of clear cell renal cell carcinoma.
Shi D; Qu Q; Chang Q; Wang Y; Gui Y; Dong D
Oncotarget; 2017 Aug; 8(35):58699-58708. PubMed ID: 28938589
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic and prognostic tissuemarkers in clear cell and papillary renal cell carcinoma.
Kroeze SG; Bijenhof AM; Bosch JL; Jans JJ
Cancer Biomark; 2010; 7(6):261-8. PubMed ID: 21694464
[TBL] [Abstract][Full Text] [Related]
34. Nucleotide excision repair deficiency is a targetable therapeutic vulnerability in clear cell renal cell carcinoma.
Prosz A; Duan H; Tisza V; Sahgal P; Topka S; Klus GT; Börcsök J; Sztupinszki Z; Hanlon T; Diossy M; Vizkeleti L; Stormoen DR; Csabai I; Pappot H; Vijai J; Offit K; Ried T; Sethi N; Mouw KW; Spisak S; Pathania S; Szallasi Z
bioRxiv; 2023 Feb; ():. PubMed ID: 36798363
[TBL] [Abstract][Full Text] [Related]
35. Clear cell renal cell carcinoma: gene expression analyses identify a potential signature for tumor aggressiveness.
Kosari F; Parker AS; Kube DM; Lohse CM; Leibovich BC; Blute ML; Cheville JC; Vasmatzis G
Clin Cancer Res; 2005 Jul; 11(14):5128-39. PubMed ID: 16033827
[TBL] [Abstract][Full Text] [Related]
36. The Landscape of Iron Metabolism-Related and Methylated Genes in the Prognosis Prediction of Clear Cell Renal Cell Carcinoma.
Mou Y; Zhang Y; Wu J; Hu B; Zhang C; Duan C; Li B
Front Oncol; 2020; 10():788. PubMed ID: 32528886
[No Abstract] [Full Text] [Related]
37. Prognosis of clear cell renal cell carcinoma (ccRCC) based on a six-lncRNA-based risk score: an investigation based on RNA-sequencing data.
Zeng JH; Lu W; Liang L; Chen G; Lan HH; Liang XY; Zhu X
J Transl Med; 2019 Aug; 17(1):281. PubMed ID: 31443717
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of FABP7 promotes cell growth and predicts poor prognosis of clear cell renal cell carcinoma.
Zhou J; Deng Z; Chen Y; Gao Y; Wu D; Zhu G; Li L; Song W; Wang X; Wu K; He D
Urol Oncol; 2015 Mar; 33(3):113.e9-17. PubMed ID: 25192834
[TBL] [Abstract][Full Text] [Related]
39. Comprehensive Analysis of Copy Number Variations in Kidney Cancer by Single-Cell Exome Sequencing.
Zhou W; Yang F; Xu Z; Luo M; Wang P; Guo Y; Nie H; Yao L; Jiang Q
Front Genet; 2019; 10():1379. PubMed ID: 32038722
[TBL] [Abstract][Full Text] [Related]
40. Dysregulation of the miRNA biogenesis components DICER1, DROSHA, DGCR8 and AGO2 in clear cell renal cell carcinoma in both a Korean cohort and the cancer genome atlas kidney clear cell carcinoma cohort.
Lee SS; Min H; Ha JY; Kim BH; Choi MS; Kim S
Oncol Lett; 2019 Oct; 18(4):4337-4345. PubMed ID: 31516620
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]